Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy

Abstract

Non-classic congenital adrenal hyperplasia (NCAH) due to 21-hydroxylase deficiency is one of the actual causes of hyperandrogenic manifestations at different age intervals. Timely diagnosis of the disease requires evaluating basal 17-hydroxyprogesterone levels during the comprehensive examination of patients of different age groups with clinical manifestations of androgen excess. This is especially important when examining adolescent girls and women of reproductive age with signs of hyperandrogenism. The obligatory examination of women when establishing the diagnosis of polycystic ovary syndrome should include the exclusion of non-classical NCAH according to all world recommendations. When 17-hydroxyprogesterone levels are in the range of 2–10 ng/ml, it is necessary to carry out cosyntropin stimulation test, which is recognized worldwide as the standard of NCAH diagnosis. The diagnostic threshold for NCAH diagnosis due to 21-hydroxylase deficiency is a level of 17-hydroxyprogesterone, basal or stimulated in cosyntropin test, higher than 10 ng/ml. Genetic testing — determining mutations in the CYP21A2 gene — is an important and necessary tool not only to confirm the diagnosis, but also to identify treatment of the patient with the diagnosis of NCAH and to determine the risk of emergence of a classic form in an unborn child in the presence of allele associated with classic САН. The recent recommendations from 2018 Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline are taken as the basis of the laboratory diagnostic criteria.

Authors and Affiliations

O. V. Rykova

Keywords

Related Articles

Substantiation for Approaches to Treatment of Latent Autoimmune Diabetes in Adults

The objective of this study was to substantiate the approaches to the treatment of latent autoimmune diabetes in adults on the basis of a comprehensive clinical examination of patients with this form of the disease. Rese...

Giant pituitary adenomas: prevalence, features of diagnosis clinical course

Based on the review of the literature, it is established that in the diagnostic complex with giant pituitary ade­nomas, in addition to clinical examination, it is necessary to use a full range of neuroimaging methods wit...

Vitamin D Deficiency and Insufficiency in Lviv Region Residents

Vitamin D is one of the important metabolites of the human body, which has a wide spectrum of effects and is a co-regulator of many important physiological processes. The aim of the study was to evaluate the incidence of...

Modern approaches to the laboratory diagnosis and management of hyperthyroidism syndrome

The lecture considers the questions of etiology, pathogeny and early diagnosis of hyperthyro- idism based on modern international guidelines. The differential diagnosis and role of laboratory methods in the treatment of...

Evaluating the Efficacy of New Structured Program for Teaching Patients with Diabetes Mellitus Type 1 in the Republic of Uzbekistan

Among 1245 patients with diabetes mellitus type 1 (children, adolescents and adults) by testing with the use of a questionnaire and determination of glycated hemoglobin we carried out evaluation of training conducted by...

Download PDF file
  • EP ID EP660859
  • DOI 10.22141/2224-0721.15.5.2019.180044
  • Views 34
  • Downloads 0

How To Cite

O. V. Rykova (2019). Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: laboratory criteria for the diagnosis and control of treatment efficacy. Міжнародний ендокринологічний журнал, 15(5), 396-401. https://europub.co.uk/articles/-A-660859